MissionIR Articles
-
Allied Healthcare Group (BOMDF) Starts Presentation at the Biotech Showcase 2013 Conference
Allied Healthcare Group is a diversified healthcare company focused on investing in next generation technologies, acquiring strategic assets to grow its product and service offerings. BOMDF operates in three businesses: Cordion, focused on vaccine technology…
-
NewLead Holdings Ltd. (NEWL) Receives $236.4 Million Investment
NewLead Holdings is an international, vertically integrated shipping and commodity company that manages double-hull product tankers and dry bulk vessels. The company currently controls four vessels, two tankers, and two dry bulk ships. The company…
-
TNI BioTech, Inc. (TNIB) Starts Presentation at the OneMedForum 2013 Conference
TNI BioTech is a biotech company engaged in combating fatal diseases through activating and mobilizing the body’s immune system using the company’s patented immunotherapy. The company’s products and immunotherapy technologies are designed to harness the…
-
Medtronic Neuromodulation (MDT) Starts Presentation at the OneMedForum 2013 Conference
Medtronic Neuromodulation is the second-oldest and fourth-largest business unit of Medtronic, Inc., the world’s leader in medical technology. Neuromodulation was formed as the company transferred its expertise in heart electrical stimulation for the treatment of…
-
Aradigm Corp. (ARDM) Starts Presentation at the Biotech Showcase 2013 Conference
Aradigm is engaged in developing inhalation drug products designed to improve the quality of life of patients with severe pulmonary disease. The company’s lead development candidates are formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150)…
-
Circadian Technologies Ltd. (CKDXF) Starts Presentation at the Biotech Showcase 2013 Conference
Circadian Technologies is engaged in angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs), the company seeks to develop truly novel therapies to extend and improve the…
-
Bacterin International Holdings, Inc. (BONE) Starts Presentation at the OneMedForum 2013 Conference
Bacterin International Holdings is a developer, manufacturer and marketer of biologics products to domestic and international markets. The company’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold…
-
InVivo Therapeutics (NVIV) Starts Presentation at the Biotech Showcase 2013 Conference
InVivo Therapeutics is focused on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The company’s aim is to develop/commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel…
-
ImmunoCellular Therapeutics (IMUC) Starts Presentation at the Biotech Showcase 2013 Conference
ImmunoCellular Therapeutics is a clinical-stage biotech company focused on the development of novel immune-based products for the treatment of cancer. The product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens, peptide…
-
Tvax Biomedical Inc. (TVAX) Starts Presentation at the Biotech Showcase 2013 Conference
Tvax Biomedical is a clinical stage drug development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. The company’s lead candidates, focused on treating brain and kidney cancer, are supported by positive…
-
CollabRX, Inc. (CLRX) Starts Presentation at the OneMedForum 2013 Conference
CollabRX is a leader in cloud-based expert systems for informing healthcare decision-making. Beginning with the area of greatest need, which is advanced cancer in patients who have effectively exhausted the standard of care, the company…
-
Atossa Genetics Inc. (ATOS) Starts Presentation at the Biotech Showcase 2013 Conference
Atossa Genetics is a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast…
-
Response Biomedical Corp. (RPBIF) Starts Presentation at the OneMedForum 2013 Conference
Response Biomedical is a developer, manufacturer and marketer of rapid onsite diagnostics tests for use with its RAMP platform for clinical and environmental applications. Representing a new paradigm in diagnostics, RAMP provides reliable laboratory-quality results…
-
Oxygen Biotherapeutics, Inc. (OXBT) Starts Presentation at the OneMedForum 2013 Conference
Oxygen Biotherapeutics is a development stage biomedical company engaged in the development of oxygen-rich intravenous and topical products. Oxycyte, the company’s proprietary perfluorocarbon (PFC) therapeutic oxygen carrier, is currently in clinical and preclinical studies for…
-
Repros Therapeutics Inc. (RPRX) Starts Presentation at the Biotech Showcase 2013 Conference
Repros Therapeutics is a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health. The company’s current product pipeline includes Androxal®, in…
-
Pressure BioSciences Inc. (PBIO) Starts Presentation at the Biotech Showcase 2013 Conference
Pressure BioSciences engages in the development and commercialization of pressure cycling technology (PCT), a patented, enabling technology platform with multiple applications in the life sciences sample preparation market. PBIO’s focus is on the development and…
-
Synthetic Biologics, Inc. (SYN) Starts Presentation at the OneMedForum 2013 Conference
Synthetic Biologics is a biotechnology company developing product candidates for serious infections and diseases. The company is developing a biologic for preventing C. diff infection as well as a series of monoclonal antibodies (mAbs) for…
-
NeoStem, Inc. (NBS) Announces Presentation of Published Research Supporting VSEL Technology at the ASH Annual Meeting
NeoStem, an emerging leader in the fast growing cell therapy market, announced the publication of papers as 2012 Annual Meeting Abstracts in the journal Blood, Volume 120, Issue 21. These publications were presented as abstracts…
-
Amarantus Bioscience Inc. (AMBS) Starts Presentation at the Biotech Showcase 2013 Conference
Amarantus Bioscience is a development-stage biotech company focused on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI) and other human diseases. The company owns…
-
Amtech Systems, Inc. (ASYS) Announces Subsidiary Recipient of Cleantech Award
Amtech Systems announced that the company’s subsidiary, Tempress Systems BV was awarded with the WNF Cleantech Star 2012, an award sponsored by the World Wide Fund for Nature The Netherlands in Rotterdam. Tempress was awarded…
Search Articles
Latest Articles
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
- MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Department of Commerce Sign Letter of Intent for $100 Million in CHIPS and Science Act Funding to Accelerate U.S. Leadership in Quantum Computing
- The Untapped Potential of Greenland’s Jameson Land Basin Creates Major Opportunity for Greenland Energy Company (NASDAQ: GLND)
- Regentis Biomaterials Ltd. (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair
- MissionIRNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Conducts First U.S. Live DefendAir Counter-Drone Demonstration